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ABSTRACT: The aim of this study was firstly to 
identify active molecules in herbs, that are traditionally 
used for the treatment of snake bite, such as Curcuma 
antinaia, Curcuma contravenenum, Andrographis 
paniculata, and Tanacetum parthenium; secondly to 
test similar structurally related molecules and finally 
to prepare and evaluate an efficient formulation 
against Ophiophagus hannah venom intoxification. 
Three labdane based compounds, including labdane 
dialdehyde, labdane lactone, and labdane trialdehyde 
and two lactones including 14-deoxy-11,12-didehydro-
andrographolide and parthenolide were isolated by 
column chromatography and characterised. Using 
the isolated rat phrenic nerve-hemidiaphragm 
preparation, the antagonistic effect of crude extracts, 
isolated compounds and prepared formulations 
were measured in vitro on the inhibition of the 
neuromuscular transmission. Inhibition on muscle 
contraction, produced by the 5 μg/mL venom, was 
reversed by test agents in organ bath preparations. A 
labdane trialdehyde, isolated from C. contravenenum, 
was identified as the best antagonising agent in the 
low micromolar range. Tests on formulations of the 
most potent C. contravenenum extract showed, that 
the suppository with witepsol H15 was an effective 
medicine against O. hannah venom. This study 
elucidated the active compounds, accounting for the 
antivenin activity of traditionally used herbs and 
suggested the most suitable formulation, which may 
help to develop potent medicines for the treatment of 
snake bite in the future.
Keywords: Antivenin activity, rat nerve-hemidiapragm, 
labdane dialdehyde, labdane trialdehyde, parthenolide, 
desoxy-andrographolide
1. Introduction
The actual incidence and the severity of snake poisoning 
are currently highly undervalued (1). The importance 
of snake bites is considered a major occupational 
disease causing both disabilities and mortalities. This 
disease is causing devastation to individuals, who are 
involved in agricultural work in the tropical regions 
worldwide. Inaccurate epidemiological data resulted 
in the underestimation of this international problem, 
which requires both high attention and sincere efforts to 
alleviate its burden (2). Based on these facts, the World 
Health Organization (WHO) is calling for new, proven 
and affordable treatments. Traditional medicine or 
herbal medicine has long been used for the treatment of 
snake bite worldwide for its affirmed effectiveness, easy 
availability, and fine economic affordability. However, 
the active ingredients contained in these herbs and most 
effective formulations are still needed to be elucidated.
 We have previously reported a labdane dialdehyde 
structure (Figure 1), which was isolated from a 
novel Curcuma zedoaroides species and exhibited 
well antivenin activity (3). Species in the genus 
Curcuma including Curcuma antinaia and Curcuma 
contravenenum were in regular use in Thailand against 
cobra intoxication, but they are very hard to find on local 
markets in Isarn today. Besides of those herbs, another 
two medical plants including Andrographis paniculata 
and Tanacetum parthenium are widely applied for the 
treatment of snake bite in India and China. Andrographis 
paniculata is in use in India as a snake venom antidote. 
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Figure 1. Chemical structure of labdane dialdehyde.
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The leaves of A. paniculata, locally known as Nilavembu, 
were grinded into a paste and applied topically at the site 
of the snake's bite (4). Tanacetum parthenium, a member 
of the Asteraceae family, which is also known as the 
Compositae family, represents a herb well known for its 
medicinal properties. Since ancient times this herb was 
used by the Greeks and the Egyptians as well as the early 
Europeans for the treatment of a number of illnesses, 
such as headaches, stomach ache, menstrual pain, joint 
pain, fever. The Chinese used this herb due to its healing 
properties against insects and snake bites (5). In order to 
further elucidate the ingredients, that account for antivenin 
activity of these herbs and develop formulations, that are 
effective against snake venom, we prepared and tested the 
in vitro antivenin activity of the crude extracts, purified 
compounds and certain formulations against Ophiophagus 
hannah venom in the present study.
2. Materials and Methods
2.1. Materials
Lyophilized O. hannah venom was obtained from the 
Queen Suavabha Memorial Institute, Bangkok, Thailand. 
The venom was dissolved in normal saline, aliquoted 
and kept at –20°C as stock solution. Herbs including 
C. zedoaroides, C. antinaia, C. contravenenum, A. 
paniculata, and T. parthenium were purchased from the 
King Cobra Village, Khon Kaen Province, Thailand. The 
chemicals and solvents were purchased from Aldrich 
(Gillingham, UK) and Lancaster Synthesis (Lancaster, 
UK). Mass spectra were obtained by Atmospheric 
Pressure Chemical Ionisation (APCI), using a Hewlett-
Packard 5989b quadrupole instrument (Vienna, Austria). 
Both proton and carbon NMR spectra were obtained on 
a Brucker AC 250 instrument (Follanden, Switzerland), 
calibrated with the solvent reference peak. Infra-red 
spectra were plotted from KBr discs on a Mattson 300 
FTIR spectrophotometer (Coventry, UK).
 Laboratory and HPLC grade dichloromethane, 
petroleum ether 60-80ºC, ethyl acetate, chloroform-d 
and methanol were purchased from Fisher-Scientific 
(Waltham, MA, USA). The Soxhlet extraction system 
was the Quickfit (C5/23) model with (24/29) joint from 
BÜCHI, Switzerland. The heating mantle used was 
the Heidolph EKT 3001 from Sigma-Aldrich, UK. 
The rotary evaporator used was the BÜCHI Rotavapor 
Model R-144, Switzerland. 1H-NMR and 13C-NMR were 
recorded in Bruker advance 400 in chloroform-d. Column 
chromatography was carried out on silica gel and thin-
layer chromatography (TLC) on TLC-silica gel 60 F254.
2.2. Preparation of crude extracts and isolation of the 
tested compounds
The rhizomes of C. zedoaroides, C. antinaia, and C. 
contravenenum (30 g of the dried, powdered rhizomes) 
were extracted with dichloromethane using a Soxhlet 
extraction apparatus, respectively. Once the Soxhlet 
extractions were completed the solvent was removed under 
reduced pressure from the round bottom flasks using a 
rotary evaporator. The extract content of C. zedoaroides, 
C. antinaia, and C. contravenenum were gathered and the 
entry code Kae1, Mia3, and Rat7 was assigned. Column 
chromoatography of the crude extract was performed using 
petroleum ether:ethyl acetate (60:40) as solvent system and 
the compounds were detected with UV light, permanganate, 
and 2,4-dinitrophenylhydrazine (DNPH). The Kae1 
extract finally provided labdane dialdehyde; Mia3 extract 
finally provided labdane dialdehyde and labdane lactone; 
Rat7 extract finally provided labdane dialdehyde, labdane 
lactone, and labdane trialdehyde. The spectra data of these 
three compounds are shown in the Appendix. 
 Fif ty grams of  dried and ground leaves of  A. 
paniculata were extracted with 500 mL of methanol 
using to a Soxhlet extractor. The solvent was evaporated 
off solvent using rotary evaporation. TLC analysis was 
performed with a dichloromethane:methanol (95:5) solvent 
mixture, and both andrographolide and 14-deoxy-11,12-
didehydroandrographolide, were purified by column 
chromatography. The spectra data of 14-deoxy-11,12-
didehydroandrographolide are shown in the Appendix.
 Fifty grams of grinded plant material T. parthenium 
was extracted with 500 mL of chloroform using a Soxhlet 
extractor. The extraction was monitored by TLC with 
ethyl acetate:petroleum ether 60-80°C (70:30) and the TLC 
plate was developed with vanillin reagent and heated at 
400°C for 1 min. Two point five gram of crude extract was 
dissolved in a minimum volume of ethyl acetate in the heat 
and 1/3 of the volume of petrol ether was added and cooled 
on ice. The yellowish sample was recrystallised from ethyl 
acetate:petroleum ether (70:30) to give parthenolide, 130 mg, 
as an off white powder. The spectra data of this compound 
are shown in the Appendix.
2.3. Preparation of C. contravenemum formulations
Ethanolic solution (entry code: OHRat7 ): For the pre-
paration of the ethanolic solution, 0.5 g of the concentrated 
extract of C. contravenemum was dissolved in 5 mL of 
ethanol and divided into two portions of 2.5 mL each. To one 
of the samples OHRat7 3 drops of trifluoroacetic acid were 
added. Both samples were incubated at 36°C for a period of 1 
week, then tested.
 Water for injection (entry code: AqRat7): For the pre-
paration of a solution for the injection, 2.5 equivalents of an 
aqueous solution of 10% Na2S2O5 to 0.2 g of the extract in 
0.1 mL DMSO were mixed until homogenous and water was 
added until a final volume of 4 mL.
 Suppositories (entry code: Rat7S): Suppositories (3 
g) containing 30% active ingredients were prepared by the 
fusion method as previously described (6). Sixty six grams 
of C. contravenemum rhizomes, giving 1.98 g crude extract, 
were extracted with 300 mL of acetone as described. The 
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3. Results and Discussion
3.1. In vitro antivenin activity of crude extracts from the 
genus Curcuma
The protecting effects of crude extracts Kae1, Mia3, 
and Rat7 from C. zedoaroides, C. antinaia, and C. 
contravenenum against O. hannah venom on the 
neuromuscular transmission of the rat phrenic nerve-
hemidiaphragm are shown in Table 1. The Kae1 extract 
was obtained in the highest yield (7%) and at a 100 
μg/mL dose the response was still above 60%. The best 
protection was determined for Rat7 extract (yield 3.0%), 
giving for the 100 μg/mL organ bath concentration a more 
than 80% of the original contraction of the diaphragm. 
Mia3 extract was obtained in the lowest yield (2.6%) 
and demonstrated the lowest antivenom activity. The 
muscle contract response was determined as 56.5% when 
expososed to 100 μg/mL of this extract.
3.2. Analysis of the ingredients in the crude extracts 
and evaluation of their antivenin activity
The crude extracts from the five medicinal herbs, used 
in the present study, were further purified and generated 
the test compounds (Figure 2). The antivenin activities of 
solvent was evaporated off to about a third of the volume 
and 6 g witepsol H15, a synthetic fat was added and the 
complete solvent was then evaporated off in vacuum. The 
homogeneous melt was poured into the suppository moulds 
and after cooling the suppositories were obtained. The 
melting point of the prepared suppositories was detected at 
32ºC.
2.4. In vitro antivenin activity assay
Spraque Dawley rats (200-250 g) were obtained from 
the Animal House, Faculty of Medicine, Khon Kaen 
University. The treatment procedures, according to 
current UK legislation, were approved by the bioethics 
committee, Faculty of Medicine, Khon Kaen University 
(HO 2434-76). Animals had free access to fresh water and 
food pellets. They were exposed to automated 12 h light 
cycles.
 Rat phrenic nerve-hemidiaphragms were prepared 
according to the staff of the Department of Pharmacology, 
University of Edinburgh (1970) and the contractile 
responses were studied. The entire nerve-muscle 
preparation was submerged in 50 mL Kreb's solution with 
carbogen and the temperature was maintained at 37°C. 
The phrenic nerve was stimulated with a rectangular-
wave pulse of 0.5 msec/0.5 Hz through a bipolar platinum 
electrode, using a Grass Model S-48 stimulator. Muscle 
contraction was recorded with a force transducer and 
Grass Polygraph recorder. The indicated doses of crude 
extract (Kae1, Mia3, and Rat7), test solutions of the 
isolated compounds in DMSO, and prepared formulations 
(OHRat7, AqRat7, and Rat7S) were added, respectively, 
to a circulating water bath at 37°C for 30 min and then 
venom was added and 30 min later the muscle contraction 
was accessed. Two phrenic nerve-hemidiaphragm 
preparations were obtained from one animal. Control, 
DMSO, was set to 100%, 5 μg/mL venom to 0%. The % 
test response (muscle contraction) was measured at 30 
min in presence of the test compounds and the venom. 
In the control group, 5 μg/mL venom alone gradually 
and completely inhibited the indirectly-evoked twitches 
within 30 min (0% response). In presence of the antidote 
the contraction remained at a certain percentage of the 
full contraction. This effect was used here to screen the 3 
Curcuma plant extracts, the isolated compounds and the 
formulations of the best plant.
Entry Code
Kae1
Mia3
Rat7
Table 1. Antivenin activity of crude extracts from Curcuma species
         Source
C. zedoaroides
C. antinaia
C. contravenenum
Yield
7.0%
2.6%
3.0%
        Composition
Labdane dialdehyde, 79%
Labdane dialdehyde, 45%
Labdane lactone, 39%
Labdane dialdehyde, 32%
Labdane lactone, 37%
Labdane trialdehyde, 8%
Muscle contraction response
32.1% (50 μg/mL); 63.1% (100 μg/mL)
26.4% (50 μg/mL); 56.5% (100 μg/mL)
53.5% (50 μg/mL); 82.6% (100 μg/mL)
Measurement time is 30 min; full contraction 100%, venom 0% at 5 μg/mL.
Figure 2. Chemical structures of the isolated compounds.
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these agents were examined and the results are shown in 
Table 2. The crude extract Kae1 from C. zedoaroides is 
a very good source of the labdane dialdehyde, which was 
obtained from this species in 79% yield and excellent 
purity, by simple column chromatography. A 10 μg/mL 
concentration of this compound showed 83% protection 
against the snake venom.
 The crude extract Mia3 from C. antinaia provided 
in addition to labdane dialdehyde, a second labdane 
derivative, identified as labdane lactone (Figure 2), 
which showed a bioactivity about 60%. Its formation can 
be understand if we assume that the labdane dialdehyde 
is oxidised to the corresponding carboxylic acid and the 
second aldehyde is able to form the hydroxyl-lactone 
structure of labdane lactone. The proportions of labdane 
dialdehyde and labdane lactone in Mia3 were detected 
as 45% and 39%, respectively. Labdane lactone was 
previously isolated from members of the Zingiberaceae 
family, which are traditionally used as a medicine 
against inflammatory diseases. This antiinflammatory 
agent regulates NF-κB-regulated cellular responses in 
particular it inhibited NF-κB activation, suppressed 
phosphorylation, p65 nuclear translocation and reporter 
gene transcription (11).
 From C. contravenenum extract Rat7, in addition to 
labdane dialdehyde and labdane lactone, a third molecule 
labdane trialdehyde (Figure 2) was finally isolated. The 
percentages of labdane dialdehyde, labdane lactone, and 
labdane trialdehyde in this extract were determined as 
32%, 37%, and 8%, respectively. Labdane trialdehyde 
21
maintained nearly a full diaphragm contraction and 
with 99.5% protection it is considered the best venom 
antidote, reported to date. Comparing the activities of 
these three molecules, the labdane trialdehyde is the most 
potent antivenin agent, followed by labdane dialdehyde 
and labdane lactone. Through analyzing the relationship 
between activities and structures of the above isolated 
compounds, the succindialdehyde structure may be 
essential and if the dialdehyde moiety was reduced to 
a diol the activity was lost (labdane diol, Figure 2). 
The labdane trialdehyde was previously isolated from 
myoga extracts on the search for inhibitors of human 
platelet aggregation and human 5-lipoxygenase. This 
compound was found to be a potent inhibitor of human 
platelet aggregation and human 5-lipoxygenase (7). The 
percentage, in which it is present in this curcuma species, 
is with 8% a good new source of this agent and therefore, 
it can be evaluated for further therapeutic applications.
 Guided by previous enzyme-linked immunosorbent 
assay (ELISA) study (8) T. parthenium (Feverfew) and 
A. paniculata were also investigated in addition to the 
Curcuma plant. From A. paniculata, andrographolide 
and 14-deoxy-11,12-didehydroandrographolide were 
isolated and tested. The desoxy-derivative displayed a 
weak inhibition of 32% at the 10 μM test concentration 
while andrographolide was found inactive as antidote. As 
14-deoxy-11,12-didehydroandrographolide is only present 
in less than 0.01% in the traditional formulation, known as 
Nilavembu, it cannot be recommended. The concentration 
and resulting of this the active amount of 14-deoxy-11,12-
didehydroandrographolide is simply too low to have any 
medicinal effect. T. parthenium is a herb well known for 
its medicinal properties. The Chinese used this herb due 
to its healing properties against insects and snake bites. 
Overall parthenolide isolated from this herb had reasonable 
antivenom activity of about 54% and it can easily be 
isolated in good quantities by crystallisation. It is the only 
European herb, which is readily available in a commercial 
formulation as a tablet from e.g. simply supplements (9).
3.3. In vitro antivenin activity of C. contravenenum 
formulations
C. contravenenum is the easiest plant in terms of plant 
production and has the biggest rhizome based on the 
total weight of the entire plant. It gave a 3.0% yield of 
the crude extract (Rat7) which exhibited most potent 
antivenin activity. For these reasons, three formulations of 
Rat7 extract were prepared and tested on their antivenin 
activity (Table 3). The ethanolic extract of Rat7 was 
Entry Code
OHRat7
AqRat7
Rat7S
Table 3. Antivenin activity of crude extracts from Curcuma species
Formulation
10% in ethanol
Hydrogensulfite adduct; 5% in water
Suppository 30%
Muscle contraction response
1.1% (500 μg/mL); 0.2% (1,000 μg/mL)
5.1% (1,000 μg/mL); 6.3% (5,000 μg/mL)
46.1% (200 μg/mL); 77.4% (400 μg/mL)
Measurement time is 30 min; full contraction 100%, venom 0% at 5 μg/mL.
Compound
Labdane dialdehyde
       1 μM
     10 μM
Labdane diol
       1 μM
     10 μM
Labdane lactone
       1 μM
     10 μM
Labdane trialdehyde
       1 μM
     10 μM
14-Deoxy-11,12-di-
dehydroandrographolide
       1 μM
     10 μM
Parthenolide
       1 μM
     10 μM
Muscle contraction response
66.1%
82.6%
                     0
  2.1%
45.6%
61.9%
83.5%
99.5%
12.2%
32.4%
29.4%
54.0%
Table 2. Antivenin activity of isolated compounds
Measurement time is 30 min; full contraction 100%, venom 0% at 5 
μg/mL.
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found inactive, and therefore formulations in Thai whisky 
cannot be recommended. Chemically, the aldehyde 
functionality has been converted into an ethoxy semi-
acetale. Thus, a protected, chemically unreactive structure 
was formed without any bioactivity. The formulation 
as hydrogen sulfite adduct was supposed to work as an 
injection in water, but again with the loss of the chemical 
reactivity the bioactivity was also lost, at least in the in 
vitro (ex vivo) experiment. The formulation of the extract 
Rat7 as a suppository worked well; in vitro 77% response 
remained for the 400 μg/mL dose, compared with the 
original extract of Rat7 at a 100 μg/mL dose, which 
gave 83% venom protection. Based on a good in vitro-in 
vivo correlation, we obtained from a previous study, 1-2 
suppositories (3 g) should translate into a working anti-
venom medication.
 Three curcuma species, i.e. C. zedoaroides, C. 
antinaia, and C. contravenenum, and two other traditional 
medicines A. paniculata, and T. parthenium were 
confirmed active against O. hannah venom in our ex-
vivo assay. In addition to the labdane dialdehyde, which 
was discovered in C. zedoaroides in our previous study, 
labdane lactone and labdane trialdehyde, isolated from 
curcuma species C. antinaia and C. contravenenum 
were found effective now against the venom. Labdane 
trialdehyde is the best anti-neurotoxic agent known 
to date. However, the isolated labdane trialdehyde is 
unstable. It is supposed, that the natural plant formulation 
is stabilising labdane trialdehyde with the labdane 
dialdehyde. Feverfew extract at high doses may be used 
for snake venom intoxication as a common European 
alternative. It should be noted, that the only efficient 
formulation is a suppository, in addition to the preparation 
of the freshly grinded root of the fresh rhizome. These 
results provided evidences about the usefulness of some 
traditional medicines as antidotes and gave clues on 
the drug development in the future. Further studies are 
ongoing to replace the in vitro antivenin assay, used in this 
study, by an in vitro method, in which chicken intestine is 
used and not laboratory animal tissue.
Acknowledgements
This study was partly supported by the Khon Kaen 
University Research Fund. We are grateful for the 
technical assistance of Wanchai Airarat.
References
1. Warrell DA. Snake bite. Lancet. 2010; 375:77-88.
2. Cruz LS, Vargas R, Lopes AA. Snakebite envenomation 
and death in the developing world. Ethn Dis. 2009; 19(1 
Suppl 1):S1-42-46.
3. Chavaeerach A, Sudmoon R, Tanee T, Mokkamul P, 
Sattayasai N, Sattayasai J. Two new species of Curcuma 
(Zingiberaceae) used as cobra-bite antidotes. J Syst 
Evolut. 2008; 46:80-88.
4. Rajadurai M, Vidhya VG, Ramya M, Bhaskar A. Ethno-
medicinal plants used by the traditional healers of 
pachamalai hills, Tamilnadu, India. Ethno-Med. 2009; 
3:39-41.
5. Lee KH, Wang HK, Itokawa H, Morris-Natschke SL. 
Current perspectives on Chinese medicines and dietary 
supplements in China, Japan and United States. Yao Wu 
Shi Pin Fen Xi. 2000; 8:219-228.
6. Adegboye TA, Itiola OA. Physical and release properties 
of metronidazole suppositories. Trop J Pharm Res. 2008; 
7:887-896.
7. Suebsasana S, Pongnaratorn P, Sattayasai J, Arkaravichien 
T, Tiamkao S, Aromdee C. Analgesic, antipyretic, anti-
inflammatory and toxic effects of andrographolide 
derivatives in experimental animals. Arch Pharm Res. 
2009; 32:1191-1200.
8. Daduang S, Sattayasai N, Sattayasai J, Tophrom P, 
Thammathaworn A, Chaveerach A, Konkchaiyaphum 
M. Screening of plants containing Naja naja siamensis 
cobra venom inhibitory activity using modified ELISA 
technique. Anal Biochem. 2005; 341:316-325.
9. Kemper K. Seven herbs every paediatrician should 
know. Contemporary Paediatrics. 1996; 13:79-90.
10. Lattmann E, Sattayasai J, Sattayasai N, Staaf A, 
Phimmasone S, Schwalbe CH, Chaveerach A. In-vitro 
and in-vivo antivenin activity of 2-[2-(5,5,8a-trimethyl-
2-methylene-decahydro-naphthalen-1-yl)-ethylidene]- 
succinaldehyde against Ophiophagus hannah venom. J 
Pharm Pharmacol. 2010; 62:257-262.
11. Kunnumakkara AB, Ichikawa H, Anand P, Mohankumar 
CJ, Hema PS, Nair MS, Aggarwal BB. Coronarin D, 
a labdane diterpene, inhibits both constitutive and 
inducible nuclear factor-κB pathway activation, leading 
to potentiation of apoptosis, inhibition of invasion, and 
suppression of osteoclastogenesis. Mol Cancer Ther. 
2008; 7:3306-3317.
12. Tiuman TS, Ueda-Nakamura T, Garcia Cortez DA, Dias 
Filho BP, Morgado-Diaz JA, de Souza W, Nakamura CV. 
Antileishmanial activity of parthenolide, a sesquiterpene 
lactone isolated from Tanacetum parthenium. Antimicrob 
Agents Chemother. 2005; 49:176-182.
 (Received January 23, 2012; Revised February 1, 2012; 
Accepted February 3, 2012)
Appendix
Labdane dialdehyde .  2-[2-(5,5,8a-Trimethyl-2-
methylene-decahydro-naphthalen-1-yl)-ethylidene]-
succinaldehyde. The 1H-NMR and 13C-NMR data are 
identical with Lattmann et al. (10).
1H-NMR (CDCl3, 300 MHz): δ: 9.7 + 9.5 (1H, 1H, 
CHO), 6.75 (1H, t, C12H), 4.90 + 4.40 (1H, 1H, s, 
C17H), 3.40 (2H, d, C14H), 2.40 (3H, m, C11H, 
C6H), 2.0-1.0 (10H, m), 0.9 + 0.8 + 0.7 (9H, s, 3×Me); 
13C-NMR: δ: 196.38, 192.60 CHO, C15 + C16; 146.96, 
133.78 C8, C13, 159.05 C12, 106.33 C17, 55.20, 54.18 
C6, C7, 32.22, 39.34 C1, C5, 34.15, 23.83,14.23 Me, 
40.54, 38.30, 38.15, 36.78, 23.55, 23.52, 18.23 C14, 
C11, C9, C10, C2, C3, C4.
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Labdane lactone. 5-Hydroxy-3-[2-(5,5,8a-trimethyl-
2-methylene-decahydro-naphthalen-1-yl)-ethylidene]-
dihydro-furan-2-one. The 1H-NMR and 13C-NMR data 
are identical with Kunnumakkara et al. (11).
1H-NMR (CDCl3, 300 MHz): δ: 6.69 (br s, 1H), 5.94 (br 
s, 1H), 4.81 (s, 1H), 4.36 (br s, 1H), 2.99 (m, 1H), 2.71 
(m, 1H), 2.40-2.36 (m, 2H), 2.20 (m, 1H), 2.05-1.08 (m, 
12H), 0.89 (s, 3H), 0.82 (s, 3H), 0.71 (s, 3H); 13C-NMR 
(75 MHz): δ: 170.65, 148.01, 143.45, 124.48, 107.52, 
96.46, 56.02, 55.21, 41.90, 39.94, 39.12, 37.68, 33.57, 
33.45, 25.58, 23.99, 21.62, 19.21, 14.23.
Labdane tr ialdehyde.  2-[2-(2-Formyl-5,5,8a-
trimethyl-decahydro-naphthalen-1-yl)-ethylidene]-
succinaldehyde. The 1H-NMR and 13C-NMR data are 
identical with Suebsasana et al. (7).
1H-NMR (CDCl3, 300 MHz): δ: 9.96 (s, 1H, H-17), 9.62 
(s, 1H, H-15), 9.50 (s, 1H, H-16), 7.10 (dd, 1H, J = 6.0, 
8.8, H-12), 3.54 (d, 1H, J = 17, H-14a), 3.48 (d, 1H, J = 
17, H-14b), 2.85 (m, 1H, J = 8.8,12, 15.2, H-11a), 2.65 
(m, 1H, J = 4, 6, 15.2, H-11b), 2.50 (m, 1H, H-8), 2.35 (m, 
1H, H-7b), 1.92 (m, 1H, H-5), 1.75 (m, 1H, H-1b), 1.60 
(m, 2H, H-6), 1.42 (m, 1H, H-3b), 1.40 (m, 2H, H-2), 1.40 
(m, 1H, H-7a), 1.22 (m, 1H, H-3a), 1.15 (m, 1H, H-1a), 
1.05 (m, 1H, H-9), 0.88 (s, 2H, H-18), 0.82 (s, 3H, H-19), 
0.80 (s, 3H, H-20); 13C-NMR (75 MHz): δ: 205.37 (C-17), 
198.84 (C-15), 194.80 (C-16), 158.72 (C-12), 138.35 
(C-13), 56.87 (C-9), 55.03 (C-5), 49.23 (C-8), 43.16 
(C-3), 40.29 (C-14), 39.88 (C-10), 39.88 (C-1), 34.25 
(C-4), 34.25 (C-18), 25.65 (C-7), 27.14 (C-11), 22.31 
(C-19), 20.11 (C-6), 19.82 (C-2), 16.16 (C-20).
14-Deoxy-11,12-didehydro-andrographolide. The 
1H-NMR and 13C-NMR data are identical with 
Suebsasana et al. (7).
1H-NMR (CDCl3, 300 MHz): δ: 7.43 (1H, t, J = 1.76 
Hz, H-14), 6.85 (1H, dd, J = 10.1 and 15.8 Hz, H-12), 
6.15 (1H, d, J = 15.8 Hz, H-11), 4.86 (2H, d, J = 1.3 Hz, 
H-15), 4.75 (1H, d, J = 1.8 Hz, 17a), 4.49 (1H, d, J = 1.8 
Hz, 17b), 4.12 (1H, d, J = 11.0 Hz, H-19a), 3.39 (1H, t, 
J = 5.3 Hz, H-3), 3.38 (1H, d, J = 11.4 Hz, H-19b), 1.22 
(3H, s, H-18), 0.83 (3H, s, H-20); 13C-NMR: δ: 172.2 
(C=O, C-16), 148.0 (C, C-8), 142.8 (CH, C-12), 136.0 
(CH, C-11), 129.2 (C, C-13), 121.1 (CH, C-14), 109.2 
(CH2, C-17), 80.8 (CH, C-3), 69.5 (CH2, C-15), 64.2 
(CH2, C-19), 61.7 (CH, C-9), 54.7 (CH, C-5), 43.0 (C, 
C-4), 38.5 (C, C-10), 38.2 (CH2, C-1), 36.6 (CH2, C-7), 
28.1 (CH2, C-2), 22.9 (CH2, C-6), 22.6 (CH3, C-18), 
15.9 (CH3, C-20).
Parthenolide. The 1H-NMR and 13C-NMR data are 
identical with Tiuman et al. (12).
1H-NMR (CDCl3, 300 MHz): δ: 6.34 (d, J = 3.6 Hz, 
H-13α), 5.62 (d, J = 3.0 Hz, H-13β), 5.21 (dd, J = 2.7, 
12.0 Hz, H-1), 3.86 (t, J = 8.4 Hz, H-6), 2.79 (d, J = 9.0 
Hz, H-5), 2.74 to 2.82 (m, H-7), 2.32 to 2.44 (m, H-9β), 
2.32 to 2.49 (m, H-2β), 2.11 to 2.21 (m, H-2α, H-3β, 
H-8α, H-9α), 1.72 (s, H-14), 1.70 to 1.77 (m, H-8β), 
1.31 (s, H-15), 1.20 to 1.28 (m, H-3α). 13C-NMR (CDCl3, 
75.5 MHz): δ: 169.3 (C-12), 139.2 (C-11), 134.6 (C-10); 
125.3 (C-1), 121.3 (C-13), 82.4 (C-6), 66.4 (C-5), 61.5 
(C-4), 47.7 (C-7), 41.2 (C-9), 36.3 (C-3), 30.6 (C-8), 
24.1 (C-2), 17.3 (C-15), 16.9 (C-14).
